J. Le Digabel, C. Lauze, J. Filiol, R. Marinescu, S. Alvarez-Georges, V. Mengeaud, G. Josse
{"title":"Proof of Concept: Home Self-Monitoring of Atopic Skin State Toward Better Emollient Compliance","authors":"J. Le Digabel, C. Lauze, J. Filiol, R. Marinescu, S. Alvarez-Georges, V. Mengeaud, G. Josse","doi":"10.1155/dth/3345481","DOIUrl":null,"url":null,"abstract":"<p>Atopic dermatitis (AD) is a high-burden disease for patients. Regular application of emollients is a prophylactic measure for maintaining a more functional skin barrier. The present study aimed at evaluating if home self-monitoring of skin barrier function by the patients themselves could lead to better compliance with emollient application and, as a result, a better skin barrier. Specifically, we aimed to assess patient autonomy in using a connected device for skin barrier measurement and the effectiveness of a personalized emollient application scheme. We conducted two studies. The first study (<i>N</i> = 12 over 4 months) tested patient autonomy in using a connected device for skin barrier measurement and evaluated the kinetics of barrier function during flares. The second study was a proof of concept (<i>N</i> = 8 over 4 months) for evaluating if a dynamic personalized scheme of emollient applications based on the skin condition measurement could improve compliance and skin condition over time. In the first study, patients easily performed skin barrier measurements at home, with skin barrier modifications observed 5 days before a flare. In the second study, patients applied more emollient and maintained a better skin barrier when guided by the personalized application scheme. The proposed approach based on home self-monitoring of the AD skin barrier associated with a personalized and dynamic scheme of emollient application appears promising for better emollient compliance and for maintaining a better skin barrier over long periods. This approach could potentially be integrated into clinical practice to enhance patient outcomes.</p><p><b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT05639738</p>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2026 1","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/dth/3345481","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatologic Therapy","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/dth/3345481","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Atopic dermatitis (AD) is a high-burden disease for patients. Regular application of emollients is a prophylactic measure for maintaining a more functional skin barrier. The present study aimed at evaluating if home self-monitoring of skin barrier function by the patients themselves could lead to better compliance with emollient application and, as a result, a better skin barrier. Specifically, we aimed to assess patient autonomy in using a connected device for skin barrier measurement and the effectiveness of a personalized emollient application scheme. We conducted two studies. The first study (N = 12 over 4 months) tested patient autonomy in using a connected device for skin barrier measurement and evaluated the kinetics of barrier function during flares. The second study was a proof of concept (N = 8 over 4 months) for evaluating if a dynamic personalized scheme of emollient applications based on the skin condition measurement could improve compliance and skin condition over time. In the first study, patients easily performed skin barrier measurements at home, with skin barrier modifications observed 5 days before a flare. In the second study, patients applied more emollient and maintained a better skin barrier when guided by the personalized application scheme. The proposed approach based on home self-monitoring of the AD skin barrier associated with a personalized and dynamic scheme of emollient application appears promising for better emollient compliance and for maintaining a better skin barrier over long periods. This approach could potentially be integrated into clinical practice to enhance patient outcomes.
期刊介绍:
Dermatologic Therapy has been created to fill an important void in the dermatologic literature: the lack of a readily available source of up-to-date information on the treatment of specific cutaneous diseases and the practical application of specific treatment modalities. Each issue of the journal consists of a series of scholarly review articles written by leaders in dermatology in which they describe, in very specific terms, how they treat particular cutaneous diseases and how they use specific therapeutic agents. The information contained in each issue is so practical and detailed that the reader should be able to directly apply various treatment approaches to daily clinical situations. Because of the specific and practical nature of this publication, Dermatologic Therapy not only serves as a readily available resource for the day-to-day treatment of patients, but also as an evolving therapeutic textbook for the treatment of dermatologic diseases.